1e
19
1
49
2
2
18
1b
1d
18
39
46
1d
2 29
1d
25
K. Rajender (Raj) Reddy, MD
78
46
Founder's Professor in Hepatology
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
40
4
3
3
1d
40
3400 Spruce Street
43 2 Dulles Liver Transplant Office
Philadelphia, PA 19104
26
43 2 Dulles Liver Transplant Office
Philadelphia, PA 19104
2e
Office: 215-662-4276
32 Fax: 215-349-5915
24
9b
12
32 Fax: 215-349-5915
24
18
Publications
23 a
3
2
29
23 a
Links
cb Search PubMed for articles
c8 Penn Medicine Liver Transplant Program
be Penn Medicine Liver Diseases Program
c
4
b
1f
cb Search PubMed for articles
c8 Penn Medicine Liver Transplant Program
be Penn Medicine Liver Diseases Program
c
13
Education:
21 d M.B.B.S. c
42 Osmania Medical College, Hyderabad, India, 1972.
c
3
3
3
3
8b
Permanent link21 d M.B.B.S. c
42 Osmania Medical College, Hyderabad, India, 1972.
c
2 29
21
1e
1d
24
5e
65
62
e 29
27
Description of Research Expertise
a7 Viral Hepatitis, Liver Cancer, Advanced Liver Disease, Liver Transplantation, HCC Biomarkers, Polycystic Liver Disease, NASH, Drug-Induced Liver Injury65
Description of Clinical Expertise
a7 Viral Hepatitis, Liver Cancer, Advanced Liver Disease, Liver Transplantation, HCC Biomarkers, Polycystic Liver Disease, NASH, Drug-Induced Liver Injury62
Description of Other Expertise
28 Education and Mentorshipe 29
23
1be Ferrante ND, Kallan MJ, Sukkestad S, Kodani M, Kitahata MM, Cachay ER, Bhattacharya D, Heath S, Napravnik S, Moore RD, Yendewa G, Mayer KH, Reddy KR, Hayden T, Kamili S, Martin JN, Kim HN, Lo Re V 3rd: Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States. J Viral Hepat Page: 879-888, Nov 2023.
14b Weinberg EM, Wong F, Vargas HE, Curry MP, Jamil K, Pappas SC, Sharma P, Reddy KR: Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin. Liver Transpl. 30: 347-355, October 2023.
103 Kulkarni AV, Lee J, Reddy KR: Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI). Expert Rev Gastroenterol Hepatol Page: 1-13, October 2023.
255 Kim J, Newcomb CW, Carbonari DM, Torgersen J, Althoff KN, Kitahata MM, Klein MB, Moore RD, Reddy KR, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Lim JK, Gill MJ, Chew K, Sterling TR, Hull M, Seaberg EC, Kirk GD, Coburn SB, Lang R, McGinnis KA, Gebo KA, Napravnik S, Kim HN, Lo Re V 3rd: North American AIDS Cohort Collaboration on Research and Design of IeDEA. Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design. PLoS One September 2023.
151 Hirshorn RE, Schaubel DE, Abt PL, Reddy KR, Bittermann T.: Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era. Liver Transpl. 30: 446-450, September 2023.
18a Flamm S, Lawitz E, Borg B, Charlton M, Landis C, Reddy KR, Shiffman M, Alsina A, Chang C, Ravendhran N, Hernandez C, Hézode C, Scherbakovsky S, Mercier RC, Samuel D. : Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis. Viruses September 2023.
116 Rosenthal BE, Abt PL, Schaubel DE, Reddy KR, Bittermann T.: Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience. Transplantation August 2023.
13b Kulkarni AV, Reddy R, Arab JP, Sharma M, Shaik S, Iyengar S, Kumar N, Sabreena, Gupta R, Premkumar GV, Menon BP, Reddy DN, Rao PN, Reddy KR: Early living donor liver transplantation for alcohol-associated hepatitis. Ann Hepatol. Jul-Aug 2023.
1ab Reddy KR, McLerran D, Marsh T, Parikh N, Roberts LR, Schwartz M, Nguyen MH, Befeler A, Page-Lester S, Tang R, Srivastava S, Rinaudo JA, Feng Z, Marrero JA. : Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: the Multi-center Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study. Gastroenterology. Gastroenterology July 2023.
2c
7
1d
1f
Selected Publications
255 Hammitt LL, Quinn D, Janczewska E, Pasquel FJ, Tytus R, Reddy KR, Abarca K, Khaertynova IM, Dagan R, Dawson R, McCauley J, Shekar T, Fu W, Pedley A, Sterling T, Tamms G, Musey L, Buchwald UK: Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors. Hum Vaccin Immunother. December 2023.1be Ferrante ND, Kallan MJ, Sukkestad S, Kodani M, Kitahata MM, Cachay ER, Bhattacharya D, Heath S, Napravnik S, Moore RD, Yendewa G, Mayer KH, Reddy KR, Hayden T, Kamili S, Martin JN, Kim HN, Lo Re V 3rd: Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States. J Viral Hepat Page: 879-888, Nov 2023.
14b Weinberg EM, Wong F, Vargas HE, Curry MP, Jamil K, Pappas SC, Sharma P, Reddy KR: Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin. Liver Transpl. 30: 347-355, October 2023.
103 Kulkarni AV, Lee J, Reddy KR: Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI). Expert Rev Gastroenterol Hepatol Page: 1-13, October 2023.
255 Kim J, Newcomb CW, Carbonari DM, Torgersen J, Althoff KN, Kitahata MM, Klein MB, Moore RD, Reddy KR, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Lim JK, Gill MJ, Chew K, Sterling TR, Hull M, Seaberg EC, Kirk GD, Coburn SB, Lang R, McGinnis KA, Gebo KA, Napravnik S, Kim HN, Lo Re V 3rd: North American AIDS Cohort Collaboration on Research and Design of IeDEA. Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design. PLoS One September 2023.
151 Hirshorn RE, Schaubel DE, Abt PL, Reddy KR, Bittermann T.: Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era. Liver Transpl. 30: 446-450, September 2023.
18a Flamm S, Lawitz E, Borg B, Charlton M, Landis C, Reddy KR, Shiffman M, Alsina A, Chang C, Ravendhran N, Hernandez C, Hézode C, Scherbakovsky S, Mercier RC, Samuel D. : Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis. Viruses September 2023.
116 Rosenthal BE, Abt PL, Schaubel DE, Reddy KR, Bittermann T.: Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience. Transplantation August 2023.
13b Kulkarni AV, Reddy R, Arab JP, Sharma M, Shaik S, Iyengar S, Kumar N, Sabreena, Gupta R, Premkumar GV, Menon BP, Reddy DN, Rao PN, Reddy KR: Early living donor liver transplantation for alcohol-associated hepatitis. Ann Hepatol. Jul-Aug 2023.
1ab Reddy KR, McLerran D, Marsh T, Parikh N, Roberts LR, Schwartz M, Nguyen MH, Befeler A, Page-Lester S, Tang R, Srivastava S, Rinaudo JA, Feng Z, Marrero JA. : Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: the Multi-center Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study. Gastroenterology. Gastroenterology July 2023.
2c